Scientists discover new cancer connection

December 14, 2016, University of Texas at Dallas

A biologist at The University of Texas at Dallas and his colleagues have discovered that two enzymes previously linked independently with keeping cancer cells alive actually work in tandem to spur tumor growth.

"There has been no reason to suspect these two proteins interact, but now we know they do. This finding was totally unexpected," said Dr. Jung-Whan (Jay) Kim, assistant professor of biological sciences and co-lead author of the study published Dec. 14 in the online journal Nature Communications.

The two enzymes Kim studied are abbreviated NQO1 and HIF-1a (pronounced "hif-one-alpha"). Under normal biological conditions, NQO1 helps protect the body from the cancer-causing damage of free radicals and environmental toxins, such as cigarette smoke. HIF-1a aids cell survival when oxygen levels in the body are temporarily low, a condition known as hypoxia. As optimal oxygen levels return, HIF-1a is degraded.

In many types of cancer tumors, however, both enzymes occur persistently at very high levels. Elevated NQO1 expression, in particular, is associated with poor prognosis in breast, colon, cervical, lung and pancreatic cancer patients, although the molecular mechanism for the elevated expression remains unclear.

Kim's group discovered a likely explanation.

"Cancer cells, like any other cells, need oxygen to survive, but they grow really fast so they become hypoxic - therefore, they suffer from low oxygen," Kim said. "They try to adapt to or overcome this hypoxic stress through various mechanisms, one of which is to increase HIF-1a. This enzyme signals the body to make more blood vessels to feed the tumor and to reprogram cellular metabolism to adapt to hypoxia.

"Until now, though, no one had made a connection between HIF-1a and NQO1," Kim said.

Kim's research group conducted a series of experiments to determine which of several proteins interact with HIF-1a. Unexpectedly, they found that NQO1 binds to HIF-1a to form a complex.

"We confirmed that they [HIF-1a and NQO1] are bound together and interacting. We also determined where in their structure they physically connect," said Kim, whose co-authors include biology graduate student Justin Goodwin BS'15, former research associate Robin Ruthenborg BS'13 MS'14 and several colleagues in South Korea. "We also characterized what happens biochemically when these two proteins are bound together."

The results show that by binding to HIF-1a in cancer cells, NQO1 regulates the partner protein by stabilizing it, preventing HIF-1a from being degraded.

"We have revealed this novel function for NQO1 in stabilizing HIF-1a, which, in turn, enhances tumor growth," Kim said.

As part of their study, the researchers examined colorectal cancer cells obtained from patients and found a significant correlation between high NQO1 and high HIF-1a levels. "Our observations provided strong supportive evidence that the two proteins physically interact," Kim said.

In subsequent experiments, the group eliminated NQO1 in colorectal and . They injected the modified cells into immunocompromised mice, whose inhibited immune systems are capable of growing human tumors. A group of control animals received unmodified tumor cells.

"We saw tumor levels drop in the mice that received cancer cells without NQO1," Kim said. "Our experiments strongly suggest that this was inhibited specifically through reduced NQO1-dependent HIF-1a activity."

Kim's UT Dallas research team is currently investigating the role of HIF-1a in certain types of lung cancers and is collaborating with Dr. Jung-Mo Anh, associate professor of chemistry and biochemistry, to identify molecules that might target and block HIF-1a in .

"We have some potentially interesting candidates, but we need further research," Kim said. "We are in the very early stages, but hopefully we will see some inhibitors emerge within the next few years."

Explore further: Stiff and oxygen-deprived tumors promote spread of cancer

More information: Eun-Taex Oh et al, NQO1 inhibits proteasome-mediated degradation of HIF-1α, Nature Communications (2016). DOI: 10.1038/NCOMMS13593

Related Stories

Stiff and oxygen-deprived tumors promote spread of cancer

September 13, 2016
When Hippocrates first described cancer around 400 B.C., he referred to the disease's telltale tumors as "karkinos"—the Greek word for crab. The "Father of Western Medicine" likely noted that cancer's creeping projections ...

Research helps clarify how obesity leads to type 2 diabetes, cancer

June 5, 2014
New findings about the biological links between obesity, insulin resistance and type 2 diabetes may also shed light on the connection between obesity and cancer, says a scientist at The University of Texas at Dallas.

Breast cancer cells use newfound pathway to survive low oxygen levels in tumors

June 20, 2016
Researchers have identified a new signaling pathway that helps cancer cells cope with the lack of oxygen found inside tumors. These are the results of a study published in Nature Cell Biology on June 20, and led by researchers ...

Low oxygen, high risk: How tumors adapt to become more aggressive

August 8, 2016
One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions. Hypoxia, or a lack of oxygen, is one example of a phenomenon that should weaken ...

Recommended for you

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.